Paladin Labs Announces the Canadian Launch of Zincofax® Spray
Announces the Launch of Unisom® Snore Relief, the Only Natural Health Product Throat Spray Available in Canada to Help Relieve Symptoms Associated with SnoringĪRIAD and Paladin Announce Commercial Distribution Agreement for Iclusig (Ponatinib) in Canada Announces Launch of New Indication for XIAFLEX® (Collagenase Clostridium Histolyticum), Broadening Its Use to the Treatment of Appropriate Patients with Peyronie's Disease Announces Approval of Envarsus PA TM (tacrolimus prolonged-release tablets) in Canadaīioprojet and Endo Jointly Announce Agreement for Paladin Labs Inc. Helsinn and Endo Announce Agreement for Paladin Labs Inc.
Movapo® (apomorphine hydrochloride) for Patients with Advanced Parkinson's Disease Now Reimbursed in Most Canadian Provinces to Commercialize Abaloparatide in CanadaĮnvarsus® PA Once-daily Immunosuppressive Therapy for Kidney and Liver Transplant Patients is Now Reimbursed in Ontario, Quebec, Manitoba and Saskatchewan Announces Approval of Wakix® (pitolisant) in CanadaĪDVANZ PHARMA and Endo Announce Partnership for Paladin Labs to Commercialize Xydalba® (dalbavancin hydrochloride) in CanadaĮndo Announces Licensing Agreement for Paladin Labs Inc. Announces the Launch of Xydalba® (dalbavancin for injection) in Canada Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.Paladin Labs Announces Health Canada’s Filing Acceptance of Cenobamate Tablets as an Adjunctive Therapy for the Management of Partial-Onset Seizures in Adults with Epilepsy The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. The company's International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, oncology, and transplantation. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays. The company's Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection ADRENALIN, a non-selective adrenergic agonist and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products, including ertapenem for injections and ephedrine sulfate injections.
#Endo international plc founder Patch#
Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture SUPPRELIN LA to treat central precocious puberty in children NASCOBAL nasal spray to treat vitamin B12 deficiency AVEED to treat hypogonadism PERCOCET to treat moderate-to-moderately-severe pain TESTOPEL an implantable pellet indicated for TRT in conditions associated with a deficiency or absence of endogenous testosterone EDEX to treat erectile dysfunction LIDODERM a topical patch product containing lidocaine for the relief of pain and products for the pain management and urology. Cooke is a businessperson who has been at the helm of 6 different companies is on the board of Alkermes. Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Independent Director, Endo International Plc Founder of Pembroke Capital Ltd., Shane M.
0 kommentar(er)
